Clinical Trial Update: Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect [Phase 3]

View source ↗

Summary

A completed Phase 3 trial comparing CARTISTEM to microfracture for knee articular cartilage injury/defect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect
• Osteoarthritis

Drugs mentioned

• CARTISTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Degenerative Osteoarthritis, Defect of Articular Cartilage | Phase 3 | Status: COMPLETED